Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reactogenicity of acellular pertussis booster vaccines in German adolescents
2005-003765-17Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2005
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Adacel Polio and COVAXIN in pertussis, diphtheria and Tetanus (2 cohorts), sponsored by Sanofi. Primary endpoint: Reactogenicity of booster vaccination (solicited local and systemic adverse events). Started Nov 2005; status: completed.
02
Drugs
Adacel PolioCOVAXIN
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on 2005-003765-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003765-17.